🇪🇺 Recombinant antithrombin (rhAT) in European Union

Recombinant antithrombin (rhAT) (Recombinant antithrombin (rhAT)) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Recombinant antithrombin (rhAT) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in European Union

Frequently asked questions

Is Recombinant antithrombin (rhAT) approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Recombinant antithrombin (rhAT) in European Union?

Mayo Clinic is the originator. The local marketing authorisation holder may differ — check the official source linked above.